Antagonist-like engagement of the TCR has been proposed to induce T cell se
lection in the thymus. However, no natural TCR ligand with TCR antagonist a
ctivity is presently known. Using a combination of bioinformatics and funct
ional testing we identified the first self-peptide that can both deliver an
tagonist-like signals and promote T cell selection in the thymus. The pepti
de is presented by appropriate MHC class I molecules in vivo. Thus, endogen
ous antagonist peptides exist and may be involved in TCR repertoire selecti
on.